This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Contact us

We are committed to supporting healthcare professionals with the resources and information they need.

BEY - Banner Image

Thank you for your interest in Beyonttra® (acoramidis)

If you’re interested in learning more about Beyonttra in ATTR-CM or would like to arrange a visit from one of our knowledgeable representatives, we’re here to help!

Please fill out the short form below and our team will get back to you promptly to address your inquiry or set up a convenient time for a visit.

We look forward to connecting with you soon.

*Please note that we will aim to respond to your request within 5 working days.
*

Abbreviation

ATTR-CM,
Transthyretin Amyloid Cardiomyopathy

 

Prescribing Information for Beyonttra® (acoramidis)

PP-BEY-GB-0026 | February 2026

Beyonttra®▼ (acoramidis) - Overview
About Beyonttra
HF-IMPACT Hub
Explore Resources and Events Focussed on Improving Management and Prognosis Through Advance Cardiac Training
PP-BEY-GB-0074, October 2025